inflammatory disorder

New consortium to advance eradication of inflammatory breast cancer

harminka — Sat, 06 Dec 2008 00:56:59 -0600

The University of Texas M. D. Anderson Cancer Center will hold the first international inflammatory breast cancer (IBC) conference on December 6-7, to bring together internationally recognized breast cancer clinicians and scientists.

New drug target for inflammatory disease

harminka — Tue, 23 Sep 2008 11:28:51 -0500

UC Davis researchers have defined a cellular process that promotes inflammation and, at the same time, found an important starting point for identifying and testing new drugs for diseases such as sepsis, rheumatoid arthritis, cardiovascular disease and some cancers.

Inflammatory disease causes blindness

harminka — Tue, 17 Jun 2008 08:24:29 -0500

People suffering from a type of connective tissue disease characterized by inflammation of arteries in the head are three times more likely to experience blindness, new Geisinger research shows.

Inflammation, depression and antidepressant response

harminka — Fri, 30 May 2008 07:28:22 -0500

Major depressive disorder is a common and complex condition that impacts about 15% of the population of the United States, yet very little is known about the mechanisms behind the psychiatric disorder. What is known is that there are clinical parallels between depressive symptoms and the symptoms of certain inflammatory disorders.

Blood clotting protein linked to rheumatoid arthritis

harminka — Sat, 17 Nov 2007 01:44:14 -0600

Researchers at Cincinnati Children’s have issued the first study showing that a protein normally involved in blood clotting (fibrin), also plays an important role in the inflammatory response and development of rheumatoid arthritis. Inflammatory joint disease appears to be driven by the engagement of inflammatory cells with fibrin matrices through a specific integrin receptor, aMB2.

Scientists link E. coli bacteria to Crohn's disease

harminka — Wed, 08 Aug 2007 05:01:48 -0500

A team of Cornell University scientists have discovered that a novel group of E. coli bacteria – containing genes similar to those described in uropathogenic and avian pathogenic E. coli and enteropathogenic bacteria such as salmonella, cholera, bubonic plague – is associated with intestinal inflammation in patients with Crohn’s disease in their research paper published July 12 by “The ISME Journal: Multidisciplinary Journal of Microbial Ecology.”

New therapy for patients with Crohn's disease

harminka — Wed, 02 May 2007 08:14:45 -0500

A study led by Mayo Clinic found that adalimumab (HUMIRAÃ‚Â®)) is an effective treatment for adults with Crohn's disease who do not respond to infliximab (REMICADEÃ‚Â®) therapy. These findings were published online today by Annals of Internal Medicine.

Remicade therapy productive in patients treated for chronic plaque psoriasis

harminka — Fri, 02 Feb 2007 13:32:35 -0600